Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika P Reategui

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Human Heredity|March 20, 2002
Single-nucleotide variant in multiple copies of a deleted in azoospermia (DAZ) sequence - a human Y chromosome quantitative polymorphismMartin N Szmulewicz, Luis M Ruiz, Erika P Reategui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Salivary soluble CD44: a potential molecular marker for head and neck cancerElizabeth J Franzmann, Erika P Reategui, Kermit L Carraway, et al.
Human Heredity|April 20, 2005
Superimposing polymorphism: the case of a point mutation within a polymorphic Alu insertionLaisel Martinez, Erika P Reategui, Libia R Fonseca, et al.
Oral Oncology|December 26, 2012
CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progressionAymee Perez, David M Neskey, Judy Wen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Soluble CD44 is a potential marker for the early detection of head and neck cancerElizabeth J Franzmann, Erika P Reategui, Felipe Pedroso, et al.
Cancer Biology & Therapy|July 21, 2006
Characterization of CD44v3-containing isoforms in head and neck cancerErika P Reategui, Adriana Antúnez de Mayolo, Parpha M Das, et al.
Head & Neck|February 2, 2012
Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinomaElizabeth J Franzmann, Erika P Reategui, Lutecia H Mateus Pereira, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 30, 2016
Risk Stratification System for Oral Cancer ScreeningLutécia H Mateus Pereira, Isildinha M Reis, Erika P Reategui, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Human Heredity|March 20, 2002
Single-nucleotide variant in multiple copies of a deleted in azoospermia (DAZ) sequence - a human Y chromosome quantitative polymorphismMartin N Szmulewicz, Luis M Ruiz, Erika P Reategui, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Salivary soluble CD44: a potential molecular marker for head and neck cancerElizabeth J Franzmann, Erika P Reategui, Kermit L Carraway, et al.
Human Heredity|April 20, 2005
Superimposing polymorphism: the case of a point mutation within a polymorphic Alu insertionLaisel Martinez, Erika P Reategui, Libia R Fonseca, et al.
Oral Oncology|December 26, 2012
CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progressionAymee Perez, David M Neskey, Judy Wen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Soluble CD44 is a potential marker for the early detection of head and neck cancerElizabeth J Franzmann, Erika P Reategui, Felipe Pedroso, et al.
Cancer Biology & Therapy|July 21, 2006
Characterization of CD44v3-containing isoforms in head and neck cancerErika P Reategui, Adriana Antúnez de Mayolo, Parpha M Das, et al.
Head & Neck|February 2, 2012
Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinomaElizabeth J Franzmann, Erika P Reategui, Lutecia H Mateus Pereira, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 30, 2016
Risk Stratification System for Oral Cancer ScreeningLutécia H Mateus Pereira, Isildinha M Reis, Erika P Reategui, et al.
Pageof 1